Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferumoxytol-enhanced MRI for lymph node metastases in genitourinary cancers
NCT02141490Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2014
- Primary completion
- Nov 2018
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferumoxytol in prostate cancer (PCa), bladder cancer, kidney cancer, sponsored by National Cancer Institute. Started May 2014; status: completed.
02
Drugs
ferumoxytol
03
Conditions
prostate cancer (PCa)bladder cancerkidney cancer
Beyond the preview
Go deeper on NCT02141490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02141490.